Prognostic Factors after Resection for Hepatocellular Carcinoma in Noncirrhotic Livers: Univariate and Multivariate Analysis World J. Surg. Vol. 27, No. 4, April 2003

Chen, Miin-Fu; Tsai, Hsiu-Pei; Jeng, Long-Bin; Lee, Wei-Chen; Yeh, Chun-Nan; Yu, Ming-Chin; Hung, Chao-Ming
April 2003
World Journal of Surgery;Apr2003, Vol. 27 Issue 4, p443
Academic Journal
The aim of this study was to investigate the prognostic factors for hepatocellular carcinoma (HCC) in patients without cirrhosis who underwent hepatectomy. Between 1986 and 1998 a total of 197 men and 57 women with noncirrhotic HCC underwent hepatic resection in the Department of Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan. We determined their surgical mortality and the disease-free and overall cumulative survival rates. The surgical mortality was 4.7% and the 5-year disease-free survival rate 24.01%. By Cox regression analysis, serum alkaline phosphatase [relative risk (RR) 1.761; 95% confidence interval (CI) 1.037–2.985)], albumin (RR 2.179; CI 1.215–3.908), multiple tumor status (RR 2.288; CI 1.272–4.115), and blood urea nitrogen (RR 4.651; CI 1.116–19.38) were shown to be independent prognostic factors for the 5-year disease-free survival rates. The 5-year overall cumulative survival rate was 25.91%. By Cox regression analysis, serum albumin (RR 1.656, CI 1.005–2.730), blood transfusion (RR 2.075, CI 1.153–3.731), resection margin (RR 2.562, CI 1.436–4.572), and multiple tumors (RR 2.801, CI 1.727–4.545) were shown to be significant independent factors that influenced cumulative survival rates. Hence in patients with a noncirrhotic HCC who underwent hepatectomy the prognosis depended on preoperative hepatic function, the presence of multiple tumors, the need for blood transfusion, and the surgical resection margin.


Related Articles

  • Risk Factors for Massive Bleeding during Major Hepatectomy. Shirabe, Ken; Kajiyama, Kiyoshi; Harimoto, Norifumi; Tsujita, Eiji; Wakiyama, Shigeki; Maehara, Yoshihiko // World Journal of Surgery;Jul2010, Vol. 34 Issue 7, p1555 

    Massive bleeding during hepatectomy is a risk for mortality and morbidity. We examined the risk factors for massive bleeding and their correlations with outcomes. The study was a retrospective case series. Among 353 consecutively hepatectomized patients, the mean estimated blood loss (EBL) was...

  • Long-term survival in a patient with hepatocellular carcinoma with resection of a metastatic lymph node after percutaneous ethanol injection therapy. Togo, Shinji; Takahashi, Tetsuya; Tanaka, Kuniya; Endo, Itaru; Sekido, Hitoshi; Shimada, Hiroshi // International Journal of Clinical Oncology;Oct2004, Vol. 9 Issue 5, p393 

    Lymph node (LN) metastases during operation for hepatocellular carcinoma (HCC), but not during operations for other cancer, as many surgeons can attest. We performed partial hepatectomy with LN dissection in a man with LN metstasis from HCC, and long-term survival was achieved. In December 1993,...

  • Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy. Motomura, Takashi; Ono, Yuki; Shirabe, Ken; Fukuhara, Takasuke; Konishi, Hideyuki; Mano, Yohei; Toshima, Takeo; Yoshiya, Shohei; Muto, Jun; Ikegami, Toru; Yoshizumi, Tomoharu; Maehara, Yoshihiko // HPB Surgery;2012, Special section p1 

    Purpose. Genetic polymorphisms of MICA and DEPDC5 have been reported to correlate with progression to hepatocellular carcinoma (HCC) in chronic hepatitis C patients. However, correlation of these genetic variants with HCC recurrence following hepatectomy has not yet been clarified. Methods....

  • Impact of the Thoracoabdominal Approach on Peri- and Postoperative Outcomes of Hepatectomy for Hepatocellular Carcinoma. Okamura, Yukiyasu; Takeda, Shin; Fujii, Tsutomu; Sugimoto, Hiroyuki; Nomoto, Shuji; Nakao, Akimasa // World Journal of Surgery;May2011, Vol. 35 Issue 5, p1042 

    Background: Resection of hepatocellular carcinoma (HCC) located in the right liver often requires hepatic mobilization. However, exposure of the HCC may be restricted when using the conventional abdominal approach (AA). In such cases, a thoracoabdominal approach (TA) can provide a good operating...

  • Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients. Xiao-Ping Chen; Fa-Zu Qiu; Wan-Yee Lau; Bi-Xiang Zhang; Yi-Fa Chen; Wan-Guang Zhang; Song-Qing He // International Journal of Colorectal Disease;May2008, Vol. 23 Issue 5, p543 

    Mesohepatectomy is a rarely used operative procedure to treat liver cancer because of its technical complexity. In patients with hepatocellular carcinoma (HCC) with a viral hepatitic/cirrhotic background, this procedure can be used to resect the tumor with adequate margins, while at the same...

  • Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension. Zhong, Jian-Hong; Li, Hang; Xiao, Nan; Ye, Xin-Ping; Ke, Yang; Wang, Yan-Yan; Ma, Liang; Chen, Jie; You, Xue-Mei; Zhang, Zhi-Yuan; Lu, Shi-Dong; Li, Le-Qun // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Background & Aims: Official guidelines do not recommend hepatic resection (HR) for patients with hepatocellular carcinoma (HCC) and portal hypertension (PHT). This study aims to investigate the safety and efficacy of HR for patients with HCC and PHT. Methods: Mortality and survival after HR...

  • Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China. Muñoz, Alvaro; Chen, Jian Guo; Egner, Patricia A.; Marshall, Melinda L.; Johnson, Jamie L.; Schneider, Michael F.; Lu, Jian Hua; Zhu, Yuan Rong; Wang, Jin-Bing; Chen, Tao Yang; Kensler, Thomas W.; Groopman, John D. // Carcinogenesis;Jun2011, Vol. 32 Issue 6, p860 

    Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with nearly 700 000 deaths occurring annually. Hepatitis B virus (HBV) is a major contributor to HCC and acquired mutations in the HBV genome may accelerate its pathogenesis. In this study, a matched case–control...

  • Hepatocellular carcinoma patients may benefit from left hemi-hepatectomy with caudate lobectomy. Hongyu Li; Bo Li; Yonggang WeI // Pakistan Journal of Medical Sciences;Jan-Mar2013, Vol. 29 Issue 1, p249 

    A letter to the editor is presented on topic related to use of left hemi-hepatectomy with caudate lobectomy as the first-line treatment for the hepatocellular carcinoma (HCC) patients having left portal vein tumor thrombus.

  • Reply to Norihiro Kokudo et al. Regional liver function is not 'zero' in the congestive area after hepatectomy with middle hepatic vein resection. Ariizumi, Shun-ichi; Yamamoto, Masakazu // Journal of Hepato -- Biliary -- Pancreatic Sciences;Jan2014, Vol. 21 Issue 1, pe2 

    A response from the authors of the article "An extended dysfunctional area in the congestive area of the remnant liver after hemi-hepatectomy with middle hepatic vein resection for liver cancers evaluated on the gadoxetic acid disodium-enhanced magnetic resonance imaging" in the 2013 issue is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics